SCHEMBL8407133

SCHEMBL8407133

CCCCN(C(=O)C(CC#N)CC#N)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
JAK2 O60674 1/20 0.48
RAB9A P51151 1/20 0.48
PAX8 Q06710 1/20 0.48
ALDH1A1 P00352 3/20 0.45
ADRB2 P07550 1/20 0.45
TP53 P04637 2/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
MAPT P10636 1/20 0.43
MLYCD O95822 2/20 0.42
GLA P06280 1/20 0.41
TSHR P16473 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
USP2 O75604 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8407138 0.85 ALDH1A1 (0.54) ALDH1A1TP53GLATSHRUSP2
SCHEMBL18997806 0.79 MLYCD (0.62) NPC1JAK2RAB9APAX8ALDH1A1
SCHEMBL2085612 0.78 NPC1 (0.58) NPC1JAK2RAB9APAX8ALDH1A1
SCHEMBL14288505 0.77 NPC1 (0.52) NPC1JAK2RAB9APAX8ALDH1A1
SCHEMBL15957135 0.77 NPC1 (0.52) NPC1JAK2RAB9APAX8ALDH1A1
SCHEMBL8407136 0.76 IDE (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL28391957 0.75 NPC1 (0.62) NPC1JAK2RAB9APAX8ALDH1A1
SCHEMBL10964238 0.75 ALDH1A1 (0.66) NPC1JAK2RAB9APAX8ALDH1A1
SCHEMBL2892022 0.75 NPC1 (0.61) NPC1JAK2RAB9APAX8ALDH1A1
SCHEMBL6003412 0.74 NPC1 (0.59) NPC1JAK2RAB9APAX8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
EP-0514056-A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry MERCK & CO. INC. (US) 1992-11-19 EP disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed
US-4282218-A ANTIANDROGENS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-08-04 US disclosed
US-4239776-A Anti-androgenic amides IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-12-16 US disclosed
EP-0002309-A2 Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1979-06-13 EP disclosed